Clinical studies on anti-obesity medications in Arab countries
Despite the growing body of research on AOMs in Arab countries, most studies remain observational and focus primarily on earlier-generation agents. There is a need for randomized controlled trials to evaluate the efficacy and safety of newer AOMs, such as semaglutide and tirzepatide, within Arab populations to inform culturally and genetically tailored obesity management strategies.
Authors
- Saleh A. Alqahtani (ORCID: https://orcid.org/0000-0003-2017-3526)
- Waleed Alhazzani (ORCID: https://orcid.org/0000-0001-8076-9626)
- Ola Alalmai
- Abdulmalik Almufarrih
- Haifa F. Alotaibi (ORCID: https://orcid.org/0000-0003-2266-7394)
- Shadan AlMuhaidib
- H Taib
- Saud Alshagrawi
- Sahar Alnaserallah
- Najla Alodah
Institutions
- Al Noor Hospitals (AE)
- Cornell University (US)
Publication Details
- Journal
- Saudi Medical Journal
- Published
- 2025-05-01
- DOI
- https://doi.org/10.15537/smj.2025.46.5.20250126
- Citations
- 2
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Ministry of Defense